Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer - Join Clinical Trial NCTNCT06958328
How to Join This Clinical Trial - NCTNCT06958328
Learn how to participate in this PHASE3 trial studying an investigational therapy for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06958328 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 98 locations. Find a study site near you:
Clinical Research Site
Gilbert, Arizona 85297 - United States
Status: RECRUITING
Clinical Research Site
Peoria, Arizona 85381 - United States
Status: RECRUITING
Clinical Research Site
Phoenix, Arizona 85027 - United States
Status: RECRUITING
Clinical Research Site
Scottsdale, Arizona 85258 - United States
Status: RECRUITING
Clinical Research Site
Surprise, Arizona 85374 - United States
Status: RECRUITING
Clinical Research Site
Tempe, Arizona 85284 - United States
Status: RECRUITING
Clinical Research Site
Jonesboro, Arkansas 72401 - United States
Status: RECRUITING
Clinical Research Site
Bakersfield, California 93301 - United States
Status: RECRUITING
Clinical Research Site
Berkeley, California 94704 - United States
Status: RECRUITING
Clinical Research Site
Cameron Park, California 95682 - United States
Status: RECRUITING
And 88 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE3 clinical trial for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships